StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
128
This month
2
This week
1
This year
12
Yesterday
1
Publishing Date
2024 - 01 - 04
2
2023 - 11 - 15
2
2023 - 06 - 27
2
2023 - 05 - 24
2
2022 - 09 - 27
2
2022 - 07 - 28
1
2022 - 07 - 12
1
2022 - 07 - 11
1
2022 - 06 - 27
1
2022 - 06 - 22
1
2022 - 06 - 16
1
2022 - 06 - 09
1
2022 - 06 - 07
2
2022 - 06 - 03
1
2022 - 06 - 02
1
2022 - 05 - 31
1
2022 - 05 - 11
1
2022 - 05 - 05
1
2022 - 04 - 21
1
2022 - 04 - 13
1
2022 - 04 - 08
1
2022 - 04 - 06
1
2022 - 03 - 31
1
2022 - 03 - 29
1
2022 - 03 - 16
1
2022 - 02 - 10
1
2022 - 02 - 09
1
2022 - 01 - 27
1
2022 - 01 - 11
1
2021 - 12 - 22
1
2021 - 12 - 21
1
2021 - 12 - 15
1
2021 - 12 - 08
1
2021 - 12 - 01
1
2021 - 11 - 30
1
2021 - 11 - 29
1
2021 - 11 - 23
1
2021 - 11 - 15
1
2021 - 11 - 11
1
2021 - 11 - 09
1
2021 - 11 - 08
1
2021 - 11 - 04
1
2021 - 11 - 02
1
2021 - 10 - 28
1
2021 - 10 - 26
1
2021 - 10 - 19
1
2021 - 10 - 12
1
2021 - 10 - 11
1
2021 - 10 - 01
1
2021 - 09 - 27
1
2021 - 09 - 09
1
2021 - 08 - 19
1
2021 - 08 - 17
1
2021 - 08 - 12
1
2021 - 08 - 09
1
2021 - 08 - 04
1
2021 - 07 - 29
1
2021 - 07 - 22
1
2021 - 07 - 13
1
2021 - 07 - 09
1
Sector
Health technology
4
Manufacturing
1
N/a
128
Tags
Acquisition
2
Agreement
2
Alliances
7
Application
7
Approval
5
Biocanada
41
Biotechnology
5
Business
4
Clearance
2
Clinical-trials-phase-i
3
Clinical-trials-phase-ii
11
Conference
22
Corporation
2
Cyb003
24
Cyb004
11
Day
2
Depression
2
Drug
7
Earnings
7
Europe
2
Events
27
Fda
8
Financial
4
Financial results
4
Flow
2
Global
3
Grant
9
Granted
3
Growth
4
Hospital
2
International
2
License
4
Major depressive disorder
7
Meeting
5
Neuropsychiatric
2
New drug
2
Offering
2
Order
4
Patent
11
People
3
Pharma
3
Phase 1
11
Phase 2
4
Positive
6
Pre-clinical
2
Preclinical
3
Presentation
3
Program
8
Psilocybin
6
Regulatory
2
Research
24
Results
12
Review
2
Study
8
Therapeutics
8
Topline
4
Train
5
Treatment
14
Trial
20
Update
3
Entities
Abbott laboratories
224
Abbvie inc.
241
Agilent technologies, inc.
114
Alnylam pharmaceuticals, inc.
162
Alphabet inc.
218
Amarin corporation plc
173
Amgen inc.
173
Arrival
119
Astrazeneca plc
151
Bausch health companies inc.
110
Becton, dickinson and company
106
Beigene, ltd.
192
Bio-techne corp
103
Biogen inc.
117
Bristol-myers squibb company
336
Bruker corporation
107
Castle biosciences, inc.
152
Charles river laboratories international, inc.
96
Cybin inc
128
Eli lilly and company
589
Evotec se
109
Gilead sciences, inc.
274
Glaxosmithkline plc
95
Horizon therapeutics public limited company
139
I-mab
117
Incyte corporation
165
Johnson & johnson
1695
Laboratory corporation of america holdings
99
Lineage cell therapeutics, inc.
101
Medtronic plc
138
Merck & company, inc.
315
Mirum pharmaceuticals, inc.
114
Moderna, inc.
289
Morgan stanley
429
Morphosys ag
284
Nanostring technologies, inc.
108
Natera, inc.
96
Nektar therapeutics
287
Novartis ag
126
Novavax, inc.
96
Novo nordisk a/s
112
Nrx pharmaceuticals inc
94
Oncocyte corporation
195
Orange
336
Perrigo company
119
Pfizer, inc.
260
Ptc therapeutics, inc.
197
Regeneron pharmaceuticals, inc.
111
Relief therapeutics holding sa
98
Sanofi
1714
Seres therapeutics, inc.
102
Takeda pharmaceutical company limited
235
Teva pharmaceutical industries ltd
117
Therapeuticsmd, inc.
227
Thermo fisher scientific inc
213
Twist bioscience corporation
161
Vaxart, inc.
221
Veracyte, inc.
106
Vertex pharmaceuticals incorporated
112
Xencor, inc.
101
Symbols
AXSM
1
BETRF
1
CYBN
128
ENVB
1
GBNH
1
JNJ
2
MDBH
1
SNY
2
SNYNF
2
Exchanges
Nasdaq
5
Nyse
128
Crawled Date
2023 - 11 - 15
2
2023 - 06 - 27
2
2023 - 05 - 24
2
2022 - 09 - 27
2
2022 - 08 - 17
1
2022 - 07 - 28
1
2022 - 07 - 12
1
2022 - 07 - 11
1
2022 - 06 - 27
1
2022 - 06 - 22
1
2022 - 06 - 16
1
2022 - 06 - 09
1
2022 - 06 - 07
2
2022 - 06 - 03
1
2022 - 06 - 02
1
2022 - 05 - 31
1
2022 - 05 - 11
1
2022 - 05 - 05
1
2022 - 04 - 21
1
2022 - 04 - 13
1
2022 - 04 - 08
1
2022 - 04 - 06
1
2022 - 03 - 31
1
2022 - 03 - 29
1
2022 - 03 - 16
1
2022 - 02 - 10
1
2022 - 02 - 09
1
2022 - 01 - 27
1
2022 - 01 - 11
1
2021 - 12 - 22
1
2021 - 12 - 21
1
2021 - 12 - 15
1
2021 - 12 - 08
1
2021 - 12 - 01
1
2021 - 11 - 30
1
2021 - 11 - 29
1
2021 - 11 - 23
1
2021 - 11 - 15
1
2021 - 11 - 11
1
2021 - 11 - 09
1
2021 - 11 - 08
1
2021 - 11 - 04
1
2021 - 11 - 02
1
2021 - 10 - 28
1
2021 - 10 - 26
1
2021 - 10 - 19
1
2021 - 10 - 12
1
2021 - 10 - 11
1
2021 - 10 - 01
1
2021 - 09 - 27
1
2021 - 09 - 09
1
2021 - 08 - 19
1
2021 - 08 - 17
1
2021 - 08 - 12
1
2021 - 08 - 09
1
2021 - 08 - 04
1
2021 - 07 - 29
1
2021 - 07 - 22
1
2021 - 07 - 13
1
2021 - 07 - 09
1
Crawled Time
00:00
1
07:00
1
08:00
1
09:00
1
11:00
2
12:00
19
12:15
2
12:20
12
12:30
5
13:00
42
13:20
4
13:30
10
14:00
9
14:20
2
15:00
1
15:20
1
15:30
3
16:00
2
17:00
1
18:00
3
19:00
1
22:00
3
23:00
2
Source
www.biospace.com
128
www.globenewswire.com
3
www.prnewswire.com
10
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Cybin inc
source :
Www.biospace.com
save search
Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry
Published:
2024-04-18
(Crawled : 14:00)
- biospace.com/
CYBN
|
News
|
$0.367
-0.78%
560K
|
n/a
|
-2.0%
|
O:
-2.0%
H:
0.0%
C:
0.0%
publication
research
Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Published:
2024-04-10
(Crawled : 13:00)
- biospace.com/
CYBN
|
News
|
$0.367
-0.78%
560K
|
n/a
|
-13.06%
|
O:
-1.96%
H:
0.0%
C:
-4.65%
conference
Cybin to Present at Public Ventures Discovery Day on March 19th in Dallas
Published:
2024-03-18
(Crawled : 17:00)
- biospace.com/
MDBH
|
$8.53
1.9K
|
|
-7.87%
|
O:
-1.69%
H:
7.09%
C:
5.26%
CYBN
|
News
|
$0.367
-0.78%
560K
|
n/a
|
-19.13%
|
O:
0.0%
H:
0.22%
C:
-2.17%
day
Cybin Initiates Phase 2 Proof-of-Concept Study of CYB004 in Generalized Anxiety Disorder
Published:
2024-03-15
(Crawled : 12:30)
- biospace.com/
CYBN
|
News
|
$0.367
-0.78%
560K
|
n/a
|
-13.29%
|
O:
1.59%
H:
7.78%
C:
5.55%
cyb004
study
Cybin Announces Positive End-of-Phase 2 Meeting with FDA for CYB003 in Major Depressive Disorder and Phase 3 Program Design
Published:
2024-03-14
(Crawled : 12:30)
- biospace.com/
CYBN
|
News
|
$0.367
-0.78%
560K
|
n/a
|
-11.43%
|
O:
7.14%
H:
5.53%
C:
-4.67%
cyb003
fda
positive
meeting
program
design
Tryp Therapeutics Announces 99.92% Votes Cast by Shareholders in Favor of Arrangement Agreement at Annual General and Special Meeting of Securityholders, and Receipt of Final Order
Published:
2024-03-12
(Crawled : 11:00)
- biospace.com/
CYBN
|
News
|
$0.367
-0.78%
560K
|
n/a
|
-6.77%
|
O:
-5.59%
H:
18.53%
C:
16.8%
meeting
order
therapeutics
agreement
Cybin Reports Third Quarter Financial Results and Recent Business Highlights
Published:
2024-02-14
(Crawled : 13:00)
- biospace.com/
CYBN
|
News
|
$0.367
-0.78%
560K
|
n/a
|
3.51%
|
O:
-1.31%
H:
0.0%
C:
-2.17%
business
financial
results
Cybin Announces Grant of Two Additional Patents in Japan in Support of its DMT Program
Published:
2024-02-07
(Crawled : 13:30)
- biospace.com/
CYBN
|
News
|
$0.367
-0.78%
560K
|
n/a
|
12.76%
|
O:
1.42%
H:
0.0%
C:
-10.34%
japan
grant
program
Tryp Therapeutics and Exopharm Limited Secure Pivotal 2 Cent Waiver From ASX
Published:
2024-01-26
(Crawled : 15:30)
- biospace.com/
CYBN
|
News
|
$0.367
-0.78%
560K
|
n/a
|
2.76%
|
O:
-0.61%
H:
2.83%
C:
2.83%
therapeutics
Cybin Announces FDA Clearance to Initiate a Phase 2a Study of CYB004 in Generalized Anxiety Disorder
Published:
2024-01-23
(Crawled : 13:30)
- biospace.com/
CYBN
|
News
|
$0.367
-0.78%
560K
|
n/a
|
-2.11%
|
O:
0.0%
H:
2.37%
C:
0.34%
cyb004
fda
clearance
study
Tryp Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial for the Treatment of Fibromyalgia at The University of Michigan
Published:
2024-01-04
(Crawled : 00:00)
- biospace.com/
CYBN
|
News
|
$0.367
-0.78%
560K
|
n/a
|
-3.13%
|
O:
0.65%
H:
3.49%
C:
3.49%
first
fibromyalgia
treatment
trial
therapeutics
Cybin Highlights Recent Topline Results and Outlines Key Upcoming Milestones Across its Clinical Development Programs
Published:
2024-01-04
(Crawled : 13:30)
- biospace.com/
CYBN
|
News
|
$0.367
-0.78%
560K
|
n/a
|
-3.13%
|
O:
0.65%
H:
3.49%
C:
3.49%
topline
results
Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Deuterated Psilocybin Analog Program
Published:
2023-12-06
(Crawled : 13:30)
- biospace.com/
CYBN
|
News
|
$0.367
-0.78%
560K
|
n/a
|
-14.38%
|
O:
-2.65%
H:
2.36%
C:
1.65%
cyb003
patent
grant
program
psilocybin
Cybin Announces Four Poster Presentations at the 2023 American College of Neuropsychopharmacology Annual Meeting Including CYB003 Phase 2 Topline Results
Published:
2023-12-05
(Crawled : 15:30)
- biospace.com/
CYBN
|
News
|
$0.367
-0.78%
560K
|
n/a
|
-16.83%
|
O:
-1.63%
H:
0.45%
C:
-1.25%
cyb003
topline
meeting
results
Cybin Reports Positive Topline Data from Phase 2 Study of CYB003 in Major Depressive Disorder with 79% of Patients in Remission after Two 12mg Doses
Published:
2023-11-30
(Crawled : 15:30)
- biospace.com/
CYBN
|
News
|
$0.367
-0.78%
560K
|
n/a
|
-22.34%
|
O:
2.3%
H:
0.0%
C:
-8.14%
cyb003
positive
topline
study
Cybin to Host CYB003 Topline Depression Study Review and R&D Briefing on November 30, 2023, in New York City
Published:
2023-11-20
(Crawled : 13:30)
- biospace.com/
CYBN
|
News
|
$0.367
-0.78%
560K
|
n/a
|
-17.33%
|
O:
2.04%
H:
0.17%
C:
-1.68%
cyb003
review
depression
city
topline
study
Cybin Announces Poster Presentation at Neuroscience 2023 Annual Meeting
Published:
2023-11-15
(Crawled : 14:00)
- biospace.com/
CYBN
|
News
|
$0.367
-0.78%
560K
|
n/a
|
-19.13%
|
O:
0.22%
H:
1.74%
C:
-1.3%
presentation
meeting
Cybin Reports Second Quarter Financial Results and Recent Business Highlights
Published:
2023-11-15
(Crawled : 08:00)
- biospace.com/
CYBN
|
News
|
$0.367
-0.78%
560K
|
n/a
|
-19.13%
|
O:
0.22%
H:
1.74%
C:
-1.3%
business
financial
results
Cybin Announces up to US$64 Million Offering of Units
Published:
2023-11-10
(Crawled : 14:00)
- biospace.com/
CYBN
|
News
|
$0.367
-0.78%
560K
|
n/a
|
-26.39%
|
O:
-12.45%
H:
3.95%
C:
-3.28%
offering
Cybin Announces Unprecedented Positive Phase 2 Interim Data for CYB003 in Major Depressive Disorder Meeting Primary Efficacy Endpoint with Rapid and Significant Improvements in Depression Symptoms After Single Dose
Published:
2023-10-31
(Crawled : 23:00)
- biospace.com/
CYBN
|
News
|
$0.367
-0.78%
560K
|
n/a
|
-38.64%
|
O:
11.35%
H:
9.32%
C:
-4.16%
JNJ
|
News
|
$146.39
0.45%
1.8M
|
Health Technology
|
-1.41%
|
O:
0.33%
H:
0.0%
C:
0.0%
AXSM
|
$67.19
2.24%
200K
|
Health Technology
|
9.48%
|
O:
0.0%
H:
3.76%
C:
3.75%
cyb003
rapid
positive
depression
meeting
← Previous
1
2
3
4
5
6
7
Next →
Gainers vs Losers
79%
21%
Top 10 Gainers
AGBA
|
News
|
$1.22
205.0%
86M
|
Finance
EGOX
|
$0.0606
68.33%
250M
|
NVFY
|
$3.45
63.51%
20M
|
Consumer Durables
CHRO
|
$1.66
35.51%
70K
|
n/a
INDO
|
$5.43
33.09%
10M
|
Energy Minerals
ZCMD
|
$1.86
28.28%
29M
|
Commercial Services
PAPL
|
$2.07
26.22%
550K
|
RWOD
|
$10.08
26.05%
5.6M
|
n/a
AULT
|
$0.3022
24.82%
51M
|
Manufacturing
HUSA
4
|
$2.07
23.95%
2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.